Role of mechanotransduction mediated by YAP/TAZ in the treatment of neurogenic erectile dysfunction with low‐intensity pulsed ultrasound
Andrology · 2023
DOI: 10.1111/andr.13438 ↗At a glance
Journal article in Andrology, 2023. Written by Yang Liu and 6 co-authors. Institution: Department of Urology, The Affiliated Hospital of Changchun University of Chinese Medicine, Changchun, China. Major MEDLINE topics: Erectile Dysfunction, Mechanotransduction, Cellular, Trauma, Nervous System. Cited 20 times so far (Crossref); 40 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Department of Science and Technology of Jilin Province.
Abstract (original language)
Background
Erectile dysfunction (ED) and weakness of the penis are processes related to hemodynamic alteration. Low‐intensity pulsed ultrasound (LIPUS), as a new mechanical modality for the treatment of ED, deserves to be explored in depth for the biomechanical mechanisms it exerts.
Objective
The aim of this study was to explore the role of YAP/TAZ‐mediated mechanotransduction in mechanical therapy for the treatment of neurogenic erectile dysfunction (NED). Materials and methods Forty‐two male SD rats (12 w old) were randomly divided into sham‐operated ( n = 14), bilateral cavernous nerve injury (BCNI, n = 14), and LIPUS‐treated ( n = 14) groups. Intracavernosal pressure/mean arterial pressure (ICP/MAP) was measured 14 and 28 days after treatment. Penile tissue specimens were collected for pathological examination, and the changes in YAP, TAZ, connective tissue growth factor (CTGF), CYR61, LATS1, and p38 mitogen‐activated protein kinase expression levels were assessed by Western blot, real‐time quantitative polymerase chain reaction (RT–qPCR) and immunological staining.
Results
Compared with BCNI, LIPUS significantly improved ICP/MAP levels and enhanced histopathological changes. The penile expression levels of YAP, TAZ, CTGF, and CYR61 were significantly downregulated in the BCNI group ( p < 0.01), and LIPUS upregulated the expression levels of these proteins ( p < 0.05). The expression levels of p‐LATS1 and LATS1 were not significantly different among the groups ( p > 0.05). Interestingly, the expression level of p‐p38/p38 significantly increased in BCNI rats ( p < 0.05), which was reversed by LIPUS treatment ( p < 0.05). However, the p38 inhibitor SB203580 did not change the expression of YAP/TAZ in rat primary smooth muscle cells or mouse MOVAS cells ( p > 0.05). Discussion and conclusion LIPUS can effectively improve penile erectile function in NED rats. The underlying mechanism may be related to the regulation of YAP/TAZ‐mediated mechanotransduction. However, the upstream regulatory signal may differ from the classical Hippo pathway.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Urology, The Affiliated Hospital of Changchun University of Chinese Medicine, Changchun, China.
ORCID profiles: Yang Liu, Yong Yang, Zhi-Tao Wei
Funding
- Department of Science and Technology of Jilin Province
Cite
APA
Liu, Y., Pan, X. Y., Zhang, X. X., Sun, J. L., Mao, Y. H., Yang, Y., & Wei, Z. T. (2023). Role of mechanotransduction mediated by YAP/TAZ in the treatment of neurogenic erectile dysfunction with low‐intensity pulsed ultrasound. Andrology. https://doi.org/10.1111/andr.13438
Vancouver
Liu Y, Pan XY, Zhang XX, Sun JL, Mao YH, Yang Y, et al. Role of mechanotransduction mediated by YAP/TAZ in the treatment of neurogenic erectile dysfunction with low‐intensity pulsed ultrasound. Andrology. 2023. doi:10.1111/andr.13438
BibTeX
@article{Liu2023,
author = {Liu, Yang and Pan, Xiao-Ying and Zhang, Xiang-Xiang and Sun, Ji-Lei and Mao, Yin-Hui and Yang, Yong and Wei, Zhi-Tao},
title = {Role of mechanotransduction mediated by YAP/TAZ in the treatment of neurogenic erectile dysfunction with low‐intensity pulsed ultrasound},
journal = {Andrology},
year = {2023},
doi = {10.1111/andr.13438}
}
EUVIMED